Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. AGEN

Market Cap: $289M

AI

Agenus Inc.

AGEN
NASDAQ (NASDAQ Capital Market)USD
Purchase AGEN
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin75.63%
EBITDA Margin1.17%
EBIT Margin1.14%
Pre-tax Margin69.29%
Net Profit Margin69.34%
Earnings Yield32.07%
Valuation Multiples
Price / Book-1.44
Price / Sales2.18
Price / Earnings2.56
PEG0.00
Forward PEG-0.02
EV / Sales2.34
EV / EBITDA2.00
EV / Operating Cash Flow-3.16
EV / Free Cash Flow-3.16
Price / Free Cash Flow-2.93
Price / Operating Cash Flow-2.91
Cash Flow & Capital
Free Cash Flow / Share-$2.38
Operating Cash Flow / Share-$2.38
Free Cash Flow Yield-34.08%
Capex / Revenue0.00%
Capex / Operating Cash Flow0.00%
Capex / Depreciation0.00
Stock Compensation / Revenue7.77%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio0.34
Quick Ratio0.34
Cash Ratio0.08
Debt / Assets0.24
Debt / Capital-0.26
Debt / Equity-0.20
Long-Term Debt / Capital0.00
Debt / Market Cap10.40%
Net Debt / EBITDA0.14
Solvency Ratio0.26
Financial Leverage-0.87
Efficiency & Working Capital
Asset Turnover0.77
Fixed Asset Turnover9.26
Inventory Turnover0.00
Receivables Turnover9.01
Payables Turnover0.55
Days Sales Outstanding40.5
Days Inventory Outstanding0
Days Payables Outstanding665.88
Operating Cycle40.5
Cash Conversion Cycle-625.37
Working Capital Turnover-0.86
Returns & Quality
Return on Equity-38.12%
Return on Assets53.28%
Return on Invested Capital-1.29%
ROCE-61.22%
Return on Tangible Assets63.14%
Operating Return on Assets20.16%
Income Quality-1.07
Tax Burden1.00
Interest Burden0.61
Balance Sheet & Intrinsic Metrics
Enterprise Value$310.97M
Invested Capital$-111.72M
Working Capital$-153.01M
Tangible Asset Value$-232.82M
Net Current Asset Value$-299.73M
Graham Net-Net-$8.44
Book Value / Share-$4.98
Tangible Book Value / Share-$5.63
Cash / Share$0.45
Financial Health Scores
Piotroski Score6
Altman Z-Score-14.34
Revenue$132.69M
EBIT$151.06M
Market Cap$286.92M
Working Capital$-153.01M
Retained Earnings$-2.14B
Total Assets$172.69M
Total Liabilities$378.54M